| 1. | Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and functional limitation: data from the Third National Health and Nutrition Examination. J Intern Med 2003;254:540–547. |
| 2. | Mannino DM, Holguin F, Pavlin BI, Ferdinands JM. Risk factors for prevalence of and mortality related to restriction on spirometry: findings from the First National Health and Nutrition Examination Survey and follow-up. Int J Tuberc Lung Dis 2005;9:613–621. |
| 3. | Scarlata S, Pedone C, Fimognari FL, Bellia V, Forastiere F, Incalzi RA. Restrictive pulmonary dysfunction at spirometry and mortality in the elderly. Respir Med 2008;102:1349–1354. |
| 4. | Guerra S, Sherrill DL, Venker C, Ceccato CM, Halonen M, Martinez FD. Morbidity and mortality associated with the restrictive spirometric pattern: a longitudinal study. Thorax 2010;65:499–504. |
| 5. | Iyer VN, Schroeder DR, Parker KO, Hyatt RE, Scanlon PD. The nonspecific pulmonary function test: longitudinal follow-up and outcomes. Chest 2011;139:878–886. |
| 6. | Mannino DM, McBurnie MA, Tan W, Kocabas A, Anto J, Vollmer WM, et al.; BOLD Collaborative Research Group. Restricted spirometry in the Burden of Lung Disease Study. Int J Tuberc Lung Dis 2012;16:1405–1411. |
| 7. | Meghji J, Nadeau G, Davis KJ, Wang D, Nyirenda MJ, Gordon SB, et al. Noncommunicable lung disease in Sub-Saharan Africa. A community-based cross-sectional study of adults in urban Malawi. Am J Respir Crit Care Med 2016;194:67–76. |
| 8. | Backman H, Eriksson B, Hedman L, Stridsman C, Jansson S-A, Sovijärvi A, et al. Restrictive spirometric pattern in the general adult population: methods of defining the condition and consequences on prevalence. Respir Med 2016;120:116–123. |
| 9. | Sood A, Petersen H, Qualls C, Meek PM, Vazquez-Guillamet R, Celli BR, et al. Spirometric variability in smokers: transitions in COPD diagnosis in a five-year longitudinal study. Respir Res 2016;17:147. |
| 10. | Siddharthan T, Grigsby M, Miele CH, Bernabe-Ortiz A, Miranda JJ, Gilman RH, et al. Prevalence and risk factors of restrictive spirometry in a cohort of Peruvian adults. Int J Tuberc Lung Dis 2017;21:1062–1068. |
| 11. | Wan ES, Fortis S, Regan EA, Hokanson J, Han MK, Casaburi R, et al.; COPDGene Investigators. Longitudinal phenotypes and mortality in preserved ratio impaired spirometry in the COPDGene study. Am J Respir Crit Care Med 2018;198:1397–1405. |
| 12. | Wijnant SRA, De Roos E, Kavousi M, Stricker BH, Terzikhan N, Lahousse L, et al. Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam Study. Eur Respir J 2020;55:1901217. |
| 13. | Marott JL, Ingebrigtsen TS, Çolak Y, Vestbo J, Lange P. Lung function trajectories leading to chronic obstructive pulmonary disease as predictors of exacerbations and mortality. Am J Respir Crit Care Med 2020;202:210–218. |
| 14. | Cox P, Miller L, Petty TL. Clinical evaluation of a new electronic spirometer. Chest 1973;63:517–519. |
| 15. | Løkke A, Marott JL, Mortensen J, Nordestgaard BG, Dahl M, Lange P. New Danish reference values for spirometry. Clin Respir J 2013;7:153–167. |
| 16. | Helweg-Larsen K. The Danish register of causes of death. Scand J Public Health 2011;39:26–29. |
| 17. | Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol 2015;7:449–490. |
| 18. | Thomsen RW, Lange P, Hellquist B, Frausing E, Bartels PD, Krog BR, et al. Validity and underrecording of diagnosis of COPD in the Danish National Patient Registry. Respir Med 2011;105:1063–1068. |
| 19. | Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials 1996;17:343–346. |
| 20. | Aalen OO, Johansen S. An empirical transition matrix for non-homogeneous Markov chains based on censored observations. Scand J Stat 1978;5:141–150. |
| 21. | Gerds TA, Scheike TH, Andersen PK. Absolute risk regression for competing risks: interpretation, link functions, and prediction. Stat Med 2012;31:3921–3930. |
| 22. | Lin DY, Wei LJ, Ying Z. Checking the Cox model with cumulative sums of martingale-based residuals. Biometrika 1993;80:557–572. |
| 23. | Tian L, Zhao L, Wei LJ. Predicting the restricted mean event time with the subject’s baseline covariates in survival analysis. Biostatistics 2014;15:222–233. |
| 24. | Petty TL. John Hutchinson’s mysterious machine revisited. Chest 2002;121:219S–223S. |
| 25. | Godfrey MS, Jankowich MD. The vital capacity is vital: epidemiology and clinical significance of the restrictive spirometry pattern. Chest 2016;149:238–251. |
| 26. | Woodruff PG, Barr RG, Bleecker E, Christenson SA, Couper D, Curtis JL, et al.; SPIROMICS Research Group. Clinical significance of symptoms in smokers with preserved pulmonary function. N Engl J Med 2016;374:1811–1821. |
| 27. | Leone N, Courbon D, Thomas F, Bean K, Jégo B, Leynaert B, et al. Lung function impairment and metabolic syndrome: the critical role of abdominal obesity. Am J Respir Crit Care Med 2009;179:509–516. |
| 28. | Jackson P, Siddharthan T. The global significance of PRISm: how data from low- and middle-income countries link physiology to inflammation. Eur Respir J 2020;55:2000184. |
| 29. | Wijnant SRA, Lahousse L, Brusselle GG. The global significance of PRISm: how data from low- and middle-income countries link physiology to inflammation. Eur Respir J 2020;55:2000354. |
| 30. | Engström G, Lind P, Hedblad B, Wollmer P, Stavenow L, Janzon L, et al. Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation 2002;106:2555–2560. |
| 31. | Lange P, Groth S, Kastrup J, Mortensen J, Appleyard M, Nyboe J, et al. Diabetes mellitus, plasma glucose and lung function in a cross-sectional population study. Eur Respir J 1989;2:14–19. |
| 32. | Perret JL, Lodge CJ, Lowe AJ, Johns DP, Thompson BR, Bui DS, et al.; TAHS investigators. Childhood pneumonia, pleurisy and lung function: a cohort study from the first to sixth decade of life. Thorax 2020;75: 28–37. |
| 33. | Svanes C, Sunyer J, Plana E, Dharmage S, Heinrich J, Jarvis D, et al. Early life origins of chronic obstructive pulmonary disease. Thorax 2010;65:14–20. |
| 34. | Agustí A, Noell G, Brugada J, Faner R. Lung function in early adulthood and health in later life: a transgenerational cohort analysis. Lancet Respir Med 2017;5:935–945. |
| 35. | Vasquez MM, Zhou M, Hu C, Martinez FD, Guerra S. Low lung function in young adult life is associated with early mortality. Am J Respir Crit Care Med 2017;195:1399–1401. |
| 36. | Allinson JP, Hardy R, Donaldson GC, Shaheen SO, Kuh D, Wedzicha JA. Combined impact of smoking and early-life exposures on adult lung function trajectories. Am J Respir Crit Care Med 2017;196:1021–1030. |
| 37. | Lange P. Development and prognosis of chronic obstructive pulmonary disease with special reference to the role of tobacco smoking. An epidemiologic study. Dan Med Bull 1992;39:30–48. |
Comments
